Literature DB >> 10497172

The potential active site of the lipoprotein-specific (type II) signal peptidase of Bacillus subtilis.

H Tjalsma1, G Zanen, G Venema, S Bron, J M van Dijl.   

Abstract

Type II signal peptidases (SPase II) remove signal peptides from lipid-modified preproteins of eubacteria. As the catalytic mechanism employed by type II SPases was not known, the present studies were aimed at the identification of their potential active site residues. Comparison of the deduced amino acid sequences of 19 known type II SPases revealed the presence of five conserved domains. The importance of the 15 best conserved residues in these domains was investigated using the type II SPase of Bacillus subtilis, which, unlike SPase II of Escherichia coli, is not essential for viability. The results showed that only six residues are important for SPase II activity. These are Asp-14, Asn-99, Asp-102, Asn-126, Ala-128, and Asp-129. Only Asp-14 was required for stability of SPase II, indicating that the other five residues are required for catalysis, the active site geometry, or the specific recognition of lipid-modified preproteins. As Asp-102 and Asp-129 are the only residues invoked in the known catalytic mechanisms of proteases, we hypothesize that these two residues are directly involved in SPase II-mediated catalysis. This implies that type II SPases belong to a novel family of aspartic proteases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497172     DOI: 10.1074/jbc.274.40.28191

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Membrane proteases in the bacterial protein secretion and quality control pathway.

Authors:  Ross E Dalbey; Peng Wang; Jan Maarten van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  An important step in listeria lipoprotein research.

Authors:  Francisco García-del Portillo; Pascale Cossart
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

Review 3.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

4.  Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.

Authors:  Andrea Hamilton; Carl Robinson; Iain C Sutcliffe; Josh Slater; Duncan J Maskell; Nick Davis-Poynter; Ken Smith; Andrew Waller; Dean J Harrington
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

5.  Inactivation of Lgt allows systematic characterization of lipoproteins from Listeria monocytogenes.

Authors:  Maja Baumgärtner; Uwe Kärst; Birgit Gerstel; Martin Loessner; Jürgen Wehland; Lothar Jänsch
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

6.  Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.

Authors:  Yao Xiao; Daniel Wall
Journal:  J Bacteriol       Date:  2014-01-03       Impact factor: 3.490

7.  In silico analysis and experimental validation of lipoprotein and novel Tat signal peptides processing in Anabaena sp. PCC7120.

Authors:  Sonika Kumari; Akhilesh Kumar Chaurasia
Journal:  J Microbiol       Date:  2015-12-02       Impact factor: 3.422

Review 8.  Secretion of bacterial lipoproteins: through the cytoplasmic membrane, the periplasm and beyond.

Authors:  Wolfram R Zückert
Journal:  Biochim Biophys Acta       Date:  2014-04-26

Review 9.  Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome.

Authors:  H Tjalsma; A Bolhuis; J D Jongbloed; S Bron; J M van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

Review 10.  Proteomics of protein secretion by Bacillus subtilis: separating the "secrets" of the secretome.

Authors:  Harold Tjalsma; Haike Antelmann; Jan D H Jongbloed; Peter G Braun; Elise Darmon; Ronald Dorenbos; Jean-Yves F Dubois; Helga Westers; Geeske Zanen; Wim J Quax; Oscar P Kuipers; Sierd Bron; Michael Hecker; Jan Maarten van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.